쇼트코스

쇼트코스에서는 지도적이고, 인터랙티브하며, 특정 토픽에 관한 상세한 정보를 제공합니다. 참가자와 강사가 1 대 1로 상호작용할 수 있으므로 메인 프레젠테이션에서는 다루지 못하는 보다 기술적인 측면을 쉽게 설명할 수 있습니다.

쇼트코스는 대면으로만 제공

Sunday, May 10, 2026

SC1: In silico and Machine Learning Tools for Antibody Design and Developability Predictions

Vinodh B. Kurella, PhD, Research Scientific Associate Director, Global Biologics, Takeda Pharmaceuticals, Inc.
Tanmoy Sanyal, PhD, Principal Data Scientist, Large Molecule Discovery Group, Amgen
Valentin Stanev, PhD, Associate Principal Data Scientist, AstraZeneca
Ben Williams, PhD, Research Software Engineer, Department of Statistics, University of Oxford

SC2: AI-Driven Predictive Preclinical Models: Rethinking the Role of Animal Testing

Sathy Balu-Iyer, PhD, Professor, Pharmaceutical Sciences, SUNY Buffalo
Panagiota (Pegy) Foteinou, PhD, Senior Director, Preclinical and Early Development, Bristol Myers Squibb
Jochem Gokemeijer, PhD, Distinguished Scientist Biologics, Biologics Discovery, Johnson & Johnson
Timothy Hickling, PhD, Consultant, Quasor Ltd.
Vibha Jawa, PhD, Chief Scientific Officer, Epivax Inc.
Pooja Khanna, PhD, Senior Scientist, Merck
Guilhem Richard, PhD, CTO, EpiVax Inc.

SC3: Challenges and Opportunities in Solid Tumor and Autoimmune Disease Therapeutics

Tony R. Arulanandam, DVM, PhD, CEO and Founder, Synaptimmune Therapeutics

SC4: Unlocking Immunity: Mastering Epitope Analysis and Prediction with IEDB and CEDAR Tools & Insights

Nina Blazeska, Senior Project Manager, IEDB and CEDAR Resources, La Jolla Institute for Immunology
Zeynep Kosaloglu-Yalcin, PhD, Instructor, La Jolla Institute for Immunology

SC5: Safety & Efficacy of Bispecifics and ADCs

Rakesh Dixit, PhD, DABT, CEO & President, Bionavigen Oncology, LLC; CSO, TMAB Therapeutics, Regio Biosciences

Tuesday, May 12, 2026

SC6: Developability of Bispecific Antibodies

Nimish Gera, PhD, Independent Consultant

SC7: Targeting the Target: Aligning Target and Biologic Format Biology to Achieve Desired Outcomes

Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC; Entrepreneur in Residence, FairJourney Biologics

SC8: The Dark Proteome: Unlocking Novel Targets for Next-Generation Biologics

Sudhakaran Prabakaran, Co-Founder & CEO, NonExomics

SC9: Automation in Action: Hands-on, Liquid Handling for Protein & Antibody Engineering

Curtis Walton, PhD, Director of Automation and Process Optimization, Institute for Protein Innovation

SC10: Best Practices and Advanced Applications for Label-Free Interaction Analysis in Therapeutic Antibody Discovery

Yasmina Abdiche, PhD, Senior Vice President, Exploratory Research, OmniAb Inc.

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_



표시하기:

Engineering
공학 스트림
Oncology
종양 스트림
Bispecific Antibodies
다중특이성 스트림
Immunotherpary
면역치료 스트림
Expression
발현 스트림
Analytical
분석법 스트림
Immunogenicity
면역원성 스트림
Emerging Modalities
신규 치료 스트림
Machine Learning Stream
기계학습 스트림

Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW   Nona_Biosciences_NEW